0001209191-18-040121.txt : 20180629 0001209191-18-040121.hdr.sgml : 20180629 20180629193211 ACCESSION NUMBER: 0001209191-18-040121 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180628 FILED AS OF DATE: 20180629 DATE AS OF CHANGE: 20180629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GORMAN KEVIN CHARLES CENTRAL INDEX KEY: 0001201096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 18930553 MAIL ADDRESS: STREET 1: 12790 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330525145 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-28 0 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001201096 GORMAN KEVIN CHARLES 12780 EL CAMINO REAL SAN DIEGO CA 92130 1 1 0 0 Chief Executive Officer Common Stock 2018-06-28 4 M 0 23168 5.76 A 370201 D Common Stock 2018-06-28 4 M 0 16551 8.66 A 386752 D Common Stock 2018-06-28 4 M 0 10199 8.65 A 396951 D Common Stock 2018-06-28 4 M 0 7142 19.59 A 404093 D Common Stock 2018-06-28 4 M 0 864 32.99 A 404957 D Incentive Stock Option 5.76 2018-06-28 4 M 0 23168 5.76 D 2011-09-25 2021-08-25 Common Stock 23168 0 D Incentive Stock Option 8.66 2018-06-28 4 M 0 16551 8.66 D 2012-02-12 2022-01-12 Common Stock 16551 0 D Incentive Stock Option 8.65 2018-06-28 4 M 0 10199 8.65 D 2013-02-10 2023-01-10 Common Stock 10199 0 D Incentive Stock Option 19.59 2018-06-28 4 M 0 7142 19.59 D 2014-02-16 2024-01-16 Common Stock 7142 0 D Incentive Stock Option 32.99 2018-06-28 4 M 0 864 32.99 D 2015-03-03 2025-02-03 Common Stock 864 3031 D Represents option of which 1/36th of the shares underlying the option vested on September 25, 2011 and an additional 1/36th of the shares underlying the option vested each month thereafter. Represents option of which 1/48th of the shares underlying the option vested on February 12, 2012 and an additional 1/48th of the shares underlying the option vested each month thereafter. Represents option of which 1/48th of the shares underlying the option vested on February 10, 2013 and an additional 1/48th of the shares underlying the option vested each month thereafter. Represents option of which 1/48th of the shares underlying the option vested on February 16, 2014 and an additional 1/48th of the shares underlying the option vested each month thereafter. Represents option of which 1/48th of the shares underlying the option vested on March 3, 2015 and an additional 1/48th of the shares underlying the option vested each month thereafter. /s/ Darin Lippoldt, Attorney-in-Fact 2018-06-29